Non-Viral Gene Therapy Retards Retinal Degeneration, Tufts University Study Says

MedGadget -- In the latest Nature Molecular Therapy a group of researchers from Tufts University is reporting using non-viral gene transfer therapy to deliver a gene that codes for a photoreceptor protecting protein produced in the eye. Not having to use viruses as a delivery mechanism avoids many potential side effects in developing future gene therapies. More from Tufts press office:

MORE ON THIS TOPIC